MedTrace Logo

Different Education Methods and Self Vulvar Examination (SVE)

NCT07479459 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to increase students' awareness about Self-Vulvar Examination (SVE), and to evaluate the effect of a peer education module and an educational brochure on students' knowledge and behaviors related to SVE.

The main questions it aims to answer are:

* Does providing peer education module and an educational brochure about SVE increase students' knowledge levels regarding SVE?
* Does providing peer education module and an educational brochure about SVE increase students' behaviors of practice SVE? Researchers will compare the peer education module and educational brochure regarding KKVM with a control group to determine whether it has an impact on students' knowledge and behavior about KKVM.

Students; After the pretest, they will learn about KKVM through a peer education module or educational brochure, or they will be in the control group.

Three months later, a posttest will assess their knowledge and behaviors about KKVM.

Conditions

  • Vulvar Self-Examination
  • Health Knowledge,Practices,Attitudes
  • Vulva Disease

Interventions

BEHAVIORAL

Brochure

A brochure about the Vulvar Self-Examination (VSE) will be distributed to this group, and a three-month follow-up will be conducted. At the end of the three-month period, a posttest will be administered to second-year students to measure changes in knowledge and behavior.

BEHAVIORAL

Peer Education

Following the peer education, students will also have a 3-month follow-up period. At the end of the 3 months, the post-test data will be collected o measure changes in knowledge and behavior.

OTHER

Control

The pre-tests were sent to the control group. As a post-test, will be administered online at the end of the 3-month follow-up period.

Sponsors & Collaborators

  • Yeditepe University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2026-01-30
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07479459 on ClinicalTrials.gov